[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  SlowBull [@SlowBullHQ](/creator/twitter/SlowBullHQ) on x XX followers Created: 2025-07-16 12:25:24 UTC $JNJ Johnson & Johnson Q2 2025 Global healthcare leader in Pharmaceuticals & MedTech ๐ฅ Outperformed across the board: delivered mid-single-digit revenue growth and EPS above consensus; raised FY25 outlook on strong cash flow & FX tailwinds ๐ฐ๐ โข Pharma: oncology led the way with robust growth & key pipeline catalysts ๐ โข MedTech: record device sales in orthopaedics & surgery ๐ฆฟ โข Consumer Health: resilient demand in skincare & wellness ๐งด โข Margins expanded thanks to cost discipline & efficiency gains ๐ โข Returned significant capital via buybacks & dividend hike ๐ธ โข Continued momentum in emerging markets ๐  XX engagements  **Related Topics** [cash flow](/topic/cash-flow) [eps](/topic/eps) [quarterly earnings](/topic/quarterly-earnings) [medtech](/topic/medtech) [coins healthcare](/topic/coins-healthcare) [$jnj](/topic/$jnj) [johnson johnson](/topic/johnson-johnson) [stocks healthcare](/topic/stocks-healthcare) [Post Link](https://x.com/SlowBullHQ/status/1945459750579417210)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
SlowBull @SlowBullHQ on x XX followers
Created: 2025-07-16 12:25:24 UTC
$JNJ Johnson & Johnson Q2 2025 Global healthcare leader in Pharmaceuticals & MedTech ๐ฅ
Outperformed across the board: delivered mid-single-digit revenue growth and EPS above consensus; raised FY25 outlook on strong cash flow & FX tailwinds ๐ฐ๐
โข Pharma: oncology led the way with robust growth & key pipeline catalysts ๐ โข MedTech: record device sales in orthopaedics & surgery ๐ฆฟ โข Consumer Health: resilient demand in skincare & wellness ๐งด โข Margins expanded thanks to cost discipline & efficiency gains ๐ โข Returned significant capital via buybacks & dividend hike ๐ธ โข Continued momentum in emerging markets ๐
XX engagements
Related Topics cash flow eps quarterly earnings medtech coins healthcare $jnj johnson johnson stocks healthcare
/post/tweet::1945459750579417210